Quince Therapeutics Inc.

NASDAQ: QNCX · Real-Time Price · USD
1.70
0.02 (1.19%)
At close: Aug 15, 2025, 3:59 PM
1.62
-4.71%
After-hours: Aug 15, 2025, 07:43 PM EDT

Quince Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-9.44M -15.03M -12.46M -5.49M -27.73M -11.15M -8.89M -5.35M -4.89M -12.25M -5.53M -7.92M -16.56M -21.64M -23.4M -21.71M -21.75M -23.09M
Depreciation & Amortization
29K 32K 16K 86K 44K 40K 304K n/a 1K 17K 42K 40K 84K 38K 84K 87K 87K 86K
Stock-Based Compensation
-6.58M 1.39M 1.13M 1.12M 1.22M 1.27M 1.09M 1.33M 1.32M 1.48M 1.63M 694K 5.05M 9.24M 8.49M 7.62M 6.75M 6.99M
Other Working Capital
2.68M 2.03M 544K 673K -1.76M -864K 377K -134K 1.5M 524K -1.15M 384K -434K -2.68M -1.83M 723K -7.33M 2.81M
Other Non-Cash Items
7.2M 1.96M 1.87M -5.21M 19.14M 2.29M 3M -719K -1.32M 5.83M -208K 1.05M 215K 135K 66.75M 11K 96K 92K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -1.82M n/a 856K -248K n/a -284K -284K n/a -66.55M 237K 240K 202K
Change in Working Capital
3.86M 2.05M 1.9M 2.23M -1.42M -805K 250K -79K 201K 1.6M -1.77M -281K -3.92M -3.86M 205K -3.59M -2.98M 2.1M
Operating Cash Flow
-4.92M -9.6M -7.55M -7.26M -8.74M -8.35M -6.08M -4.82M -3.83M -3.57M -5.83M -6.7M -15.41M -16.09M -14.42M -17.34M -17.56M -13.61M
Capital Expenditures
-269K -148K -133K -46K -39K -39K -24K n/a n/a -136K -78K -50K -10.63M -5K -44K n/a -99K -37K
Cash Acquisitions
-135K n/a n/a n/a n/a n/a -2.12M n/a n/a 90K 10.43M 35K 10.63M 135K 878K n/a n/a 202K
Purchase of Investments
-4.83M -1.95M n/a -3.84M -46.43M -39.29M -18.66M -44.98M -42.44M -7.69M -8.25M -29.92M -27.89M -8.96M -3.01M -10.61M -13.19M -11.98M
Sales Maturities Of Investments
8.04M 12.64M 10.51M 9.13M 41.49M 48.24M 26.7M 49.12M 22.12M 13.28M 27M 21.11M 12.01M 22.38M 23.97M 11.38M 18.91M 43.66M
Other Investing Acitivies
725K 355K 490K 1.86M n/a n/a -500K -500K -20.32K 5.68K -10.43M 35K 10.63M -135K -878K 766K 5.72M -202K
Investing Cash Flow
3.52M 10.9M 10.87M 7.11M -4.98M 8.91M 5.39M 3.63M -20.32M 5.54M 18.67M -8.83M -5.25M 13.41M 20.92M 766K 5.62M 31.64M
Debt Repayment
n/a n/a n/a n/a n/a n/a -6K n/a n/a -6K -18K -19K n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 16.5M n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
13.88M n/a n/a -5M n/a n/a 6K n/a 26K 56K n/a 14K 108K 14K 990K 4.71M 672K 441K
Financial Cash Flow
13.88M 87K n/a -5M 35K 190K 57K 10K 26K 50K -18K -5K 108K 622K 990K 4.71M 672K 441K
Net Cash Flow
-50.74M 1.56M 3.54M -5.21M -13.92M 1.06M -880K -1.02M -24.06M 2.13M 12.77M -15.12M -20.64M -2.16M 7.52M -11.84M -11.27M 18.47M
Free Cash Flow
-5.19M -9.75M -7.68M -7.31M -8.78M -8.39M -6.1M -4.82M -3.83M -3.71M -5.91M -6.75M -26.04M -16.1M -14.46M -17.34M -17.66M -13.65M